Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 177

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy

Open access
Cunningham, Jane, Jones, Sophie, Gatton, Michelle L., Barnwell, John W., Cheng, Qin, Chiodini, Peter L., Glenn, Jeffrey, Incardona, Sandra, Kosack, Cara, Luchavez, Jennifer, Menard, Didier, Nhem, Sina, Oyibo, Wellington, Rees-Channer, Roxanne R., Gonzalez, Iveth, Bell, David · 2019 · Malaria Journal

Abstract

Malaria rapid diagnostic tests (RDTs) emerged in the early 1990s into largely unregulated markets, and uncertain field performance was a major concern for the acceptance of tests for malaria case management. This, combined with the need to guide procurement decisions of UN agencies and WHO Member States, led to the creation of an independent, internationally coordinated RDT evaluation programme aiming to provide comparative performance data of commercially available RDTs. Products were assessed against Plasmodium falciparum and Plasmodium vivax samples diluted to two densities, along with malaria-negative samples from healthy individuals, and from people with immunological abnormalities or non-malarial infections. Three measures were established as indicators of performance, (i) panel detection score (PDS) determined against low density panels prepared from P. falciparum and P. vivax wild-type samples, (ii) false positive rate, and (iii) invalid rate, and minimum criteria defined. Over eight rounds of the programme, 332 products were tested. Between Rounds 1 and 8, substantial improvements were seen in all performance measures. The number of products meeting all criteria increased from 26.8% (11/41) in Round 1, to 79.4% (27/34) in Round 8. While products submitted to further evaluation rounds under compulsory re-testing did not show improvement, those voluntarily resubmitted showed significant increases in P. falciparum (p = 0.002) and P. vivax PDS (p < 0.001), with more products meeting the criteria upon re-testing. Through this programme, the differentiation of products based on comparative performance, combined with policy changes has been influential in the acceptance of malaria RDTs as a case-management tool, enabling a policy of parasite-based diagnosis prior to treatment. Publication of product testing results has produced a transparent market allowing users and procurers to clearly identify appropriate products for their situation, and could form a model for introduction of other, broad-scale diagnostics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12936-019-3028-z

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 177

Metadata

Authors
Cunningham, J., Jones, S., Gatton, M. L., Barnwell, J. W., Cheng, Q., Chiodini, P. L., Glenn, J., Incardona, S., Kosack, C., Luchavez, J., Menard, D., Nhem, S., Oyibo, W., Rees-Channer, R. R., Gonzalez, I., & Bell, D.
Venue
Malaria Journal
Published
2019-12
Volume
18
Issue
1
Pages
387-387
ISSN
1475-2875 (ISSN-L)
OpenAlex
W2993000058
Cited by
177
References
2
FWCI
15.39
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy. https://app.cochat.ai/papers/10.1186/s12936-019-3028-z
The paper
Cunningham, J., Jones, S., Gatton, M. L., Barnwell, J. W., Cheng, Q., Chiodini, P. L., Glenn, J., Incardona, S., Kosack, C., Luchavez, J., Menard, D., Nhem, S., Oyibo, W., Rees-Channer, R. R., Gonzalez, I., & Bell, D. (2019). A review of the WHO malaria rapid diagnostic test product testing programme (2008–2018): performance, procurement and policy. Malaria Journal. https://doi.org/10.1186/s12936-019-3028-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.